CatalYm Appoints Christian S. Schade as Chairman of the Board of Directors
Christian S. Schade, the former CEO and Chairman of Aprea Therapeutics (2016-2023), has been appointed Chairman of the Board of Directors at CatalYm. Mr. Schade brings over 30 years of executive experience, most recently leading Halda Therapeutics through its $3.05 billion acquisition by Johnson & Johnson in December 2025.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.